British Columbia Investment Management Corp Charles River Laboratories International, Inc. Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 8,594 shares of CRL stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,594

Previous 9,834 12.61%

Holding current value

$1.6 Million

Previous $2.03 Million 16.69%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $233,070 - $304,159	-1,240 Reduced 12.61%	8,594 $1.69 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $8.52 Million - $11.1 Million	-41,290 Reduced 80.76%	9,834 $2.03 Million
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $45,588 - $61,248	224 Added 0.44%	51,124 $13.9 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $208,446 - $302,610	1,267 Added 2.55%	50,900 $12 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $777,760 - $870,440	4,000 Added 8.77%	49,633 $9.73 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $17,085 - $19,553	93 Added 0.2%	45,633 $9.59 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $12,664 - $17,154	66 Added 0.15%	45,540 $9.19 Million
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $2.06 Million - $2.61 Million	10,450 Added 29.84%	45,474 $9.9 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $1.42 Million - $1.95 Million	7,789 Added 28.6%	35,024 $6.89 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $1.01 Million - $1.5 Million	-4,956 Reduced 15.4%	27,235 $5.83 Million
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $2.32 Million - $3.28 Million	-9,066 Reduced 21.97%	32,191 $9.14 Million
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $1.2 Million - $1.54 Million	-3,429 Reduced 7.67%	41,257 $15.5 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $6.92 Million - $8.51 Million	-18,559 Reduced 29.34%	44,686 $18.4 Million
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $2.75 Million - $3.47 Million	9,345 Added 17.34%	63,245 $23.4 Million
Q1 2021 Apr 30, 2021	SELL	$249.67 - $299.48 $1.55 Million - $1.86 Million	-6,200 Reduced 10.32%	53,900 $15.6 Million
Q4 2020 Feb 02, 2021	SELL	$222.0 - $252.62 $1.67 Million - $1.89 Million	-7,500 Reduced 11.09%	60,100 $15 Million
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $948,024 - $1.22 Million	-5,400 Reduced 7.4%	67,600 $15.3 Million
Q2 2020 Aug 12, 2020	BUY	$118.84 - $189.72 $3.24 Million - $5.18 Million	27,300 Added 59.74%	73,000 $12.7 Million
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $2.41 Million - $4.35 Million	24,400 Added 114.55%	45,700 $5.77 Million
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $2.68 Million - $3.25 Million	21,300 New	21,300 $3.25 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Charles River Laboratories International, Inc. Transaction History